Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kian Kani

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 12, 2017
Quantitative Proteomics Using SILACKian Kani
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2011
Investigation of acquired resistance to EGFR-targeted therapies in lung cancer using cDNA microarraysKian Kani, Rafaella Sordella, Parag Mallick
Biochemistry|November 30, 2005
The extracellular domains of ErbB3 retain high ligand binding affinity at endosome pH and in the locked conformationKian Kani, Euisun Park, Ralf Landgraf
The Journal of Biological Chemistry|July 11, 2006
The N-terminal domains of neuregulin 1 confer signal attenuationCarmen M Warren, Kian Kani, Ralf Landgraf
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2012
Functional isolation of activated and unilaterally phosphorylated heterodimers of ERBB2 and ERBB3 as scaffolds in ligand-dependent signalingQian Zhang, Euisun Park, Kian Kani, et al.
Journal of Visualized Experiments : Jove|October 9, 2018
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody ArraysKatrin Tiemann, Carolina Garri, Jeffrey Wang, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 7, 2011
Model-based discovery of circulating biomarkersMaryann S Vogelsang, Kian Kani, Jonathan E Katz, et al.
Cancer Informatics|December 31, 2015
Simulation of the Protein-Shedding Kinetics of a Fully Vascularized TumorHermann B Frieboes, Louis T Curtis, Min Wu, et al.
The Journal of Biological Chemistry|December 22, 2004
Oligomers of ERBB3 have two distinct interfaces that differ in their sensitivity to disruption by heregulinKian Kani, Carmen M Warren, Catherine S Kaddis, et al.
Endocrine-Related Cancer|March 8, 2017
Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cellsChun-Peng Liao, Leng-Ying Chen, Andrea Luethy, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|February 12, 2017
Quantitative Proteomics Using SILACKian Kani
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2011
Investigation of acquired resistance to EGFR-targeted therapies in lung cancer using cDNA microarraysKian Kani, Rafaella Sordella, Parag Mallick
Biochemistry|November 30, 2005
The extracellular domains of ErbB3 retain high ligand binding affinity at endosome pH and in the locked conformationKian Kani, Euisun Park, Ralf Landgraf
The Journal of Biological Chemistry|July 11, 2006
The N-terminal domains of neuregulin 1 confer signal attenuationCarmen M Warren, Kian Kani, Ralf Landgraf
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2012
Functional isolation of activated and unilaterally phosphorylated heterodimers of ERBB2 and ERBB3 as scaffolds in ligand-dependent signalingQian Zhang, Euisun Park, Kian Kani, et al.
Journal of Visualized Experiments : Jove|October 9, 2018
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody ArraysKatrin Tiemann, Carolina Garri, Jeffrey Wang, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 7, 2011
Model-based discovery of circulating biomarkersMaryann S Vogelsang, Kian Kani, Jonathan E Katz, et al.
Cancer Informatics|December 31, 2015
Simulation of the Protein-Shedding Kinetics of a Fully Vascularized TumorHermann B Frieboes, Louis T Curtis, Min Wu, et al.
The Journal of Biological Chemistry|December 22, 2004
Oligomers of ERBB3 have two distinct interfaces that differ in their sensitivity to disruption by heregulinKian Kani, Carmen M Warren, Catherine S Kaddis, et al.
Endocrine-Related Cancer|March 8, 2017
Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cellsChun-Peng Liao, Leng-Ying Chen, Andrea Luethy, et al.
Pageof 3